• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估白细胞计数作为口腔癌潜在预后标志物的情况。

Evaluation of white blood cell count as a possible prognostic marker for oral cancer.

作者信息

Kruse Astrid L, Luebbers Heinz T, Grätz Klaus W

机构信息

University Hospital Zurich, Department of Craniomaxillofacial and Oral Surgery, Zurich/Switzerland.

出版信息

Head Neck Oncol. 2011 Feb 27;3:13. doi: 10.1186/1758-3284-3-13.

DOI:10.1186/1758-3284-3-13
PMID:21352591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3058112/
Abstract

INTRODUCTION

There seems to be increasing evidence that inflammation leads to cancer. For several cancers, an association with white blood cell (WBC) count has been reported. So far, no studies have been performed for cancer of the oral cavity and WBC. Therefore, the aim of the present study was to look at whether WBC count can be used as a prognostic marker for recurrence or metastases for oral cancer.

MATERIAL AND METHODS

For 278 patients with oral cancer, the preoperative WBC count was compared with the clinicopathological information: age, gender, T-status, N-status, recurrence, metastases, follow-up time, and time till recurrence or metastases appeared.

RESULTS

Out of 278 patients, 48 developed recurrence, 24 second tumors, 46 cervical metastases, and 14 distant metastases. The mean follow-up time was 35.97 months (range: 12-107 months). Significant Pearson correlation at the 0.05 level could be found for the T-status (0.046), but not for the N status (0.121). No significant correlation could be found between WBC count and the development of recurrence or metastases.

CONCLUSION

In conclusion, our findings demonstrate that elevated WBC count does not seem to be a predictor for recurrence or for further metastases. Further research is recommended to investigate the WBC count in precancerous lesions and in HPV positive patients with oral SCC.

摘要

引言

越来越多的证据表明炎症会引发癌症。对于几种癌症,已有报告称其与白细胞(WBC)计数有关。迄今为止,尚未针对口腔癌与白细胞进行相关研究。因此,本研究的目的是探讨白细胞计数是否可作为口腔癌复发或转移的预后标志物。

材料与方法

对278例口腔癌患者,将术前白细胞计数与临床病理信息进行比较,这些信息包括年龄、性别、T分期、N分期、复发情况、转移情况、随访时间以及出现复发或转移的时间。

结果

278例患者中,48例出现复发,24例出现第二原发肿瘤,46例出现颈部转移,14例出现远处转移。平均随访时间为35.97个月(范围:12 - 107个月)。在0.05水平上,T分期有显著的皮尔逊相关性(0.046),而N分期无显著相关性(0.121)。白细胞计数与复发或转移的发生之间未发现显著相关性。

结论

总之,我们的研究结果表明白细胞计数升高似乎并非复发或进一步转移的预测指标。建议进一步研究癌前病变以及HPV阳性的口腔鳞状细胞癌患者的白细胞计数情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/b1302bbf018d/1758-3284-3-13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/03d4b78d92c6/1758-3284-3-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/33c321eb7146/1758-3284-3-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/c739ee723be4/1758-3284-3-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/cea54accaa9e/1758-3284-3-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/b1302bbf018d/1758-3284-3-13-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/03d4b78d92c6/1758-3284-3-13-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/33c321eb7146/1758-3284-3-13-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/c739ee723be4/1758-3284-3-13-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/cea54accaa9e/1758-3284-3-13-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb1b/3058112/b1302bbf018d/1758-3284-3-13-5.jpg

相似文献

1
Evaluation of white blood cell count as a possible prognostic marker for oral cancer.评估白细胞计数作为口腔癌潜在预后标志物的情况。
Head Neck Oncol. 2011 Feb 27;3:13. doi: 10.1186/1758-3284-3-13.
2
Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer.复发诊断时白细胞计数升高是复发性宫颈癌患者生存时间短的指标。
Int J Gynecol Cancer. 2012 Nov;22(9):1545-51. doi: 10.1097/IGC.0b013e31826ea0eb.
3
An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma.术前血红蛋白水平作为口腔鳞状细胞癌预后因素的评估
Head Neck Oncol. 2011 Aug 15;3:35. doi: 10.1186/1758-3284-3-35.
4
Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.115例T1-T2期口腔鳞状细胞癌患者的临床病理参数、复发情况、局部区域及远处转移情况
Head Neck Oncol. 2010 Apr 20;2:9. doi: 10.1186/1758-3284-2-9.
5
Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer.口腔癌患者治疗前循环单核细胞计数与预后不良相关。
Head Neck. 2014 Jul;36(7):947-53. doi: 10.1002/hed.23400. Epub 2014 Jan 16.
6
Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma.潜在恶性疾病、口腔鳞状细胞癌及口腔鳞状细胞癌治疗病例中血清铁蛋白水平的评估。
J Cancer Res Ther. 2017 Jul-Sep;13(3):550-555. doi: 10.4103/0973-1482.181182.
7
Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.使用一组新的代谢血液生物标志物作为液体活检来监测一例口腔鳞状细胞癌的致癌过程。
Oral Maxillofac Surg. 2016 Sep;20(3):295-302. doi: 10.1007/s10006-016-0549-2. Epub 2016 Feb 13.
8
The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.口腔和口咽鳞状细胞癌患者淋巴结转移模式的预后影响。
Eur Arch Otorhinolaryngol. 2004 May;261(5):270-5. doi: 10.1007/s00405-003-0678-8. Epub 2003 Sep 18.
9
Pretreatment thrombocytosis: a prognostic marker for oral squamous cell carcinoma?
Oral Maxillofac Surg. 2012 Jun;16(2):197-200. doi: 10.1007/s10006-011-0305-6. Epub 2011 Nov 24.
10
Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients.血源性细胞角蛋白20信使核糖核酸作为口腔癌患者复发的预测标志物。
Br J Cancer. 1999 May;80(3-4):448-52. doi: 10.1038/sj.bjc.6690377.

引用本文的文献

1
Prognostic value of inflammation-based markers in advanced or metastatic neuroendocrine tumours.炎症标志物在晚期或转移性神经内分泌肿瘤中的预后价值。
Curr Oncol. 2019 Feb;26(1):e30-e38. doi: 10.3747/co.26.4135. Epub 2019 Feb 1.
2
Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.头颈部癌症患者治疗前实验室值的预后影响。
J Cancer Res Clin Oncol. 2013 Jan;139(1):171-8. doi: 10.1007/s00432-012-1320-1. Epub 2012 Sep 25.
3
Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.

本文引用的文献

1
Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma.血清 C 反应蛋白作为口腔鳞状细胞癌患者的预后指标。
Oral Oncol. 2009 Oct;45(10):912-4. doi: 10.1016/j.oraloncology.2009.03.015. Epub 2009 Jun 6.
2
C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.头颈部癌患者的C反应蛋白水平与放射性黏膜炎
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):393-8. doi: 10.1016/j.ijrobp.2008.11.012. Epub 2009 Apr 11.
3
Is C-reactive protein a prognostic factor of colorectal cancer?
口腔鳞状细胞癌患者新的治疗前实验室预后指标的临床相关性。
Med Oncol. 2012 Sep;29(3):1435-47. doi: 10.1007/s12032-011-0045-3. Epub 2011 Aug 19.
C反应蛋白是结直肠癌的一个预后因素吗?
Dis Colon Rectum. 2008 Apr;51(4):443-9. doi: 10.1007/s10350-007-9133-z. Epub 2008 Jan 3.
4
Genetic tools to tailor cancer prevention by NSAIDs.通过非甾体抗炎药定制癌症预防的基因工具。
Discov Med. 2006 Apr;6(32):71-4.
5
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.C反应蛋白水平、C反应蛋白基因变异与癌症风险:鹿特丹研究
J Clin Oncol. 2006 Nov 20;24(33):5216-22. doi: 10.1200/JCO.2006.07.1381.
6
Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.循环白细胞计数与年龄相关性黄斑变性的长期发病率之间的关联:蓝山眼研究
Am J Epidemiol. 2007 Feb 15;165(4):375-82. doi: 10.1093/aje/kwk022. Epub 2006 Nov 16.
7
White blood cell count and the risk of colon cancer.白细胞计数与患结肠癌的风险。
Yonsei Med J. 2006 Oct 31;47(5):646-56. doi: 10.3349/ymj.2006.47.5.646.
8
A prospective study of serum C-reactive protein and colorectal cancer risk in men.一项关于男性血清C反应蛋白与结直肠癌风险的前瞻性研究。
Cancer Res. 2006 Feb 15;66(4):2483-7. doi: 10.1158/0008-5472.CAN-05-3631.
9
White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans.韩国人群队列中白细胞计数与全因、心血管疾病及癌症死亡率的风险
Am J Epidemiol. 2005 Dec 1;162(11):1062-9. doi: 10.1093/aje/kwi326. Epub 2005 Oct 12.
10
Leukocyte count and coronary heart disease: implications for risk assessment.白细胞计数与冠心病:对风险评估的影响
J Am Coll Cardiol. 2004 Nov 16;44(10):1945-56. doi: 10.1016/j.jacc.2004.07.056.